The roles of IL-17A in inflammatory immune responses and host defense against pathogens

被引:405
作者
Iwakura, Yoichiro [1 ]
Nakae, Susumu [2 ]
Saijo, Shinobu
Ishigame, Harumichi
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Tokyo 1088639, Japan
基金
日本学术振兴会;
关键词
IL-17A; IL-1; inflammation; allergic disease; autoimmune disease; bacterial infection;
D O I
10.1111/j.1600-065X.2008.00699.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T-helper 17 (Th17) cells are a newly discovered CD4(+) helper T-cell subset that produces interleukin-17A (IL-17A) and IL-17F. IL-17A plays important roles in allergic responses such as delayed-type hypersensitivity, contact hypersensitivity, and allergic airway inflammation. IL-17A promotes inflammation by inducing various proinflammatory cytokines and chemokines, recruiting neutrophils, enhancing antibody production, and activating T cells. IL-17A expression is also augmented in autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Using mouse models of these diseases, we found that IL-17A plays a central role in their development. IL-6 is required for the development of Th17 cells and tumor necrosis factor functions downstream of IL-17A during the effector phase. IL-1 is important both for developing Th17 cells and eliciting inflammation. Th17 cells, like Th1 and Th2 cells, are involved in host defense against infections, but the contribution of these Th subsets to defense mechanisms differs among pathogens. The roles of IL-17F remain largely unknown. In this review, we introduce how IL-17A/IL-17F are involved in inflammatory immune responses and host defense mechanisms and discuss their relationship with other cytokines in the development of inflammatory and infectious diseases.
引用
收藏
页码:57 / 79
页数:23
相关论文
共 299 条
[1]   Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis [J].
Abdollahi-Roodsaz, Shahla ;
Joosten, Leo A. B. ;
Koenders, Marije I. ;
Devesa, Isabel ;
Roelofs, Mieke F. ;
Radstake, Timothy R. D. J. ;
Heuvelmans-Jacobs, Marleen ;
Akira, Shizuo ;
Nicklin, Martin J. H. ;
Ribeiro-Dias, Fatima ;
Van den Berg, Wim B. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :205-216
[2]   Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-γ-independent pathway [J].
Afanasyeva, M ;
Wang, Y ;
Kaya, Z ;
Stafford, EA ;
Dohmen, KM ;
Akha, AAS ;
Rose, NR .
CIRCULATION, 2001, 104 (25) :3145-3151
[3]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[4]   Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-γ via CXCR3 chemokines [J].
Akahira-Azuma, M ;
Szczepanik, M ;
Tsuji, RF ;
Campos, RA ;
Itakura, A ;
Mobini, N ;
McNiff, J ;
Kawikova, I ;
Lu, B ;
Gerard, C ;
Pober, JS ;
Askenase, PW .
IMMUNOLOGY, 2004, 111 (03) :306-317
[5]   Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes [J].
Albanesi, C ;
Scarponi, CS ;
Cavani, A ;
Federici, M ;
Nasorri, F ;
Girolomoni, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (01) :81-87
[6]  
Albanesi C, 1999, J IMMUNOL, V162, P494
[7]   Interleukin 6 is required for the development of collagen-induced arthritis [J].
Alonzi, T ;
Fattori, E ;
Lazzaro, D ;
Costa, P ;
Probert, L ;
Kollias, G ;
De Benedetti, F ;
Poli, V ;
Ciliberto, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :461-468
[8]   Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma [J].
Amin, K ;
Lúdvíksdóttir, D ;
Janson, C ;
Nettelbladt, O ;
Björnsson, E ;
Roomans, GM ;
Boman, G ;
Sevéus, L ;
Venge, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2295-2301
[9]   ANTIBODIES TO NATIVE AND DENATURED COLLAGENS IN SERA OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
ANDRIOPOULOS, NA ;
MESTECKY, J ;
MILLER, EJ ;
BRADLEY, EL .
ARTHRITIS AND RHEUMATISM, 1976, 19 (03) :613-617
[10]  
Antonysamy MA, 1999, J IMMUNOL, V162, P577